Suppressed networks of inflammatory mediators characterize chronic venous insufficiency

Ulka Sachdev*, Lena Vodovotz, Julie Bitner, Derek Barclay, Ruben Zamora, Jinling Yin, Richard L. Simmons, Yoram Vodovotz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Objective: Chronic venous insufficiency (CVI) affects 25 million adults in the United States. Little emphasis has been placed on inflammatory changes associated with CVI. We hypothesize that in patients with early to mid-stage benign varicose vein disease, differences in circulating inflammatory mediators will be manifested in blood draining the involved area vs circulating blood in control subjects. Methods: Patients undergoing either endovenous ablation or sclerotherapy for Clinical, Etiology, Anatomy, and Pathophysiology clinical class 3 to 5 disease underwent phlebotomy from regional veins at the time of the procedure. The patient's age, gender, clinical class, duration of symptoms, presence of superficial truncal reflux by duplex ultrasound, and treatment modality were recorded. Plasma from patients and banked blood samples from healthy volunteers (HVs) were subjected to Luminex (EMD Millipore, Billerica, Mass) to evaluate the expression of an established panel of 20 inflammatory mediators. Mediator concentrations were compared between patients and HVs using Mann-Whitney U tests. Importantly, computational analysis allowed us to compare not only the panel of inflammatory mediators but also the inflammatory networks connecting these mediators to one another. Principal components were analyzed to assess network robustness in each group. Results: CVI venous blood revealed significantly lower levels of monokine induced by γ interferon, soluble interleukin (IL) 2 receptor α chain, IL-4, IL-6, IL-7, tumor necrosis factor α eotaxin, and granulocyte-macrophage colony-stimulating factor than blood from controls. Inflammatory networks were significantly less complex and less robust in the CVI patients compared with HVs. Based on principal component analysis, responses among HVs were more varied than those of CVI patients. Conclusions: We demonstrate that patients with CVI have significant differences not only in blood-borne inflammatory mediators but also in the interconnectedness of these mediators with one another and in their principal inflammatory characteristics. Results suggest hypoinflammation in chronic nonhealing changes in CVI. These novel findings, if validated in larger cohorts, may help predict the risk of disease progression or response to therapy in the future and may guide mechanistic studies on tissue responses to CVI. Clinical Relevance: Chronic venous insufficiency (CVI) affects 25 million adults in the United States. Whereas most patients present with relatively benign varicose veins, 2 to 6 million people are affected by severe disease associated with ulceration. Relatively little emphasis has been placed on systemic inflammatory changes associated with CVI, particularly in states in which tissue loss is not a feature. We demonstrate that patients with CVI without tissue loss demonstrate significant differences in inflammatory mediator networks compared with control subjects. Specifically and somewhat surprisingly, inflammatory networks in patients are less robust than in controls and may signify a dysregulated state in venous hypertension.

Original languageEnglish
Pages (from-to)358-366
Number of pages9
JournalJournal of Vascular Surgery: Venous and Lymphatic Disorders
Issue number3
StatePublished - May 2018
Externally publishedYes


Dive into the research topics of 'Suppressed networks of inflammatory mediators characterize chronic venous insufficiency'. Together they form a unique fingerprint.

Cite this